An efficient synthesis of the orally-active GpIIb/IIIa antagonist FR184764

Tetrahedron Letters

Volumn 45, Issue 13, 2004, Pages 2843-2845

  Yamanaka, Toshio ^a   Ohkubo, Mitsuru ^a   Takahashi, Fumie ^a   Kato, Masayuki ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

FR184764; GpIIb IIIa antagonist; Lipase catalyzed kinetic resolution; Orally active

Indexed keywords

ESTER DERIVATIVE; ETHYNYL BETA AMINO ESTER; FIBRINOGEN RECEPTOR ANTAGONIST; FRI 184764; FRI 84764; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DRUG SYNTHESIS; KINETICS; METHODOLOGY;

EID: 1542268869     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2004.01.157     Document Type: Article

References (13)

1. For reviews, see; Agah R., Plow E.F., Topol E.J. Platelets. 2002;769.
2. Mousa S.A. Drug Discovery Today. 4:1999;552. and references cited therein.
3. Zablocki J.A., Rico J.G., Garland R.B., Rogers T.E., Williams K., Schretzman L.A., Rao S.A., Bovy P.R., Tjoeng F.S., Lindmark R.J., Toth M.V., Zupec M.E., McMackins D.E., Adams S.P., Miyano M., Markos C.S., Milton M.N., Paulson S., Herin M., Jacqmin P., Nicholson N.S., Panzer-Knodle S.G., Haas N.F., Page J.D., Szalony J.A., Taite B.B., Salyers A.K., King L.W., Campion J.G., Feigen L.P. J. Med. Chem. 38:1995;2378.
4. Cossy J., Schmitt A., Cinquin C., Buisson D., Belotti D. Bioorg. Med. Chem. Lett. 7:1997;1699.
5. Topgi R.S., Ng J.S., Landis B., Wang P., Behling J.R. Bioorg. Med. Chem. 7:1999;2221.
6. Magnus P., Thurston L.S. J. Org. Chem. 56:1991;1166.
7. Nagai H., Shiozawa T., Achiwa K., Terao Y. Chem. Pharm. Bull. 40:1992;2227.
8. idem, ibid. 1993, 41, 1933.
9. Purchased from Amano Enzyme Inc.
10. 3).
11. Ohkubo, M; Takahashi, F.; Yamanaka, T.; Sakai, H.; Kato, M. International Patent WO 9508536.
12. Related synthesis was reported. Boys M.L. Tetrahedron Lett. 39:1998;3449.
13. 2O: C, 59.58; H, 7.74; N, 10.77. Found: C, 59.59; H, 7.78; N, 10.89.